Ir al contenido

Oncología

Planificación antes del tratamiento y optimización del paciente

Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. (abre una nueva ventana)

Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology.

Fuente‎: Br J Anaesth 2014;113(3):416-23.

Indexado en‎: PubMed 24829444

DOI‎: 10.1093/bja/aeu098

https://www.ncbi.nlm.nih.gov/pubmed/24829444 (abre una nueva ventana)

Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation. (abre una nueva ventana)

Bonello VA, Bhangu A, Fitzgerald JE, Rasheed S, Tekkis P.

Fuente‎: Tech Coloproctol 2014;18(10):887-93.

Indexado en‎: PubMed 24890577

DOI‎: 10.1007/s10151-014-1150-z

https://www.ncbi.nlm.nih.gov/pubmed/24890577 (abre una nueva ventana)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (abre una nueva ventana)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Fuente‎: Ann Med Surg (Lond) 2016;6:6-11.

Indexado en‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (abre una nueva ventana)

The theory and practice of bloodless surgery. (abre una nueva ventana)

Martyn V, Farmer SL, Wren MN, Towler SC, Betta J, Shander A, Spence RK, Leahy MF.

Fuente‎: Transfus Apher Sci 2002;27(1):29-43.

Indexado en‎: PubMed 12201468

https://www.ncbi.nlm.nih.gov/pubmed/12201468 (abre una nueva ventana)

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes. (abre una nueva ventana)

Simou M, Thomakos N, Zagouri F, Vlysmas A, Akrivos N, Zacharakis D, Papadimitriou CA, Dimopoulos MA, Rodolakis A, Antsaklis A.

Fuente‎: World J Surg Oncol 2011;9:142.

Indexado en‎: PubMed 22051161

DOI‎: 10.1186/1477-7819-9-142

https://www.ncbi.nlm.nih.gov/pubmed/22051161 (abre una nueva ventana)

Effects of trilaciclib on chemotherapy-induced myelosuppression and patient-reported outcomes in patients with extensive-stage small cell lung cancer: Pooled results from three phase ii randomized, double-blind, placebo-controlled studies. (abre una nueva ventana)

Weiss J, Goldschmidt J, Andric Z, Dragnev KH, Gwaltney C, Skaltsa K, Pritchett Y, Antal JM, Morris SR, Daniel D

Fuente‎: Clin Lung Cancer 2021;22(5):449-60. 

Indexado en‎: PubMed 33895103

DOI‎: 10.1016/j.cllc.2021.03.010

https://pubmed.ncbi.nlm.nih.gov/33895103/ (abre una nueva ventana)

Adverse effects on hemostatic function of drugs used in hematologic malignancies. (abre una nueva ventana)

Zakarija A, Kwaan HC.

Fuente‎: Semin Thromb Hemost 2007;33(4):355-64.

Indexado en‎: PubMed 17525893

DOI‎: 10.1055/s-2007-976171

https://www.ncbi.nlm.nih.gov/pubmed/17525893 (abre una nueva ventana)